Evidence map›Paper›PMID 24330474›Full record

ArticleBMC musculoskeletal disorders2013

Analysis of mass spectrometry data from the secretome of an explant model of articular cartilage exposed to pro-inflammatory and anti-inflammatory stimuli using machine learning.

Anna L Swan, Kirsty L Hillier, Julia R Smith, David Allaway, Susan Liddell, Jaume Bacardit, Ali Mobasheri

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. In Vitro Models and Proteomics in Osteoarthritis Research.Advances in experimental medicine and biology · 2023
    Review
  4. Machine Learning in Rheumatic Diseases.Clinical reviews in allergy & immunology · 2021
    Review
  5. Article
  6. Aging-related inflammation in osteoarthritis.Osteoarthritis and cartilage · 2015
    Review
  7. Applying computation biology and "big data" to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2015
    Review
  8. Article
  9. Proteomic Analysis of Engineered Cartilage.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anna L Swan
Kirsty L Hillier
Julia R Smith
David Allaway
Susan Liddell
Jaume Bacardit
Ali MobasheriMusculoskeletal Research Group, School of Veterinary Medicine and Science, Faculty of Medicine and Health Science, University of Nottingham, Sutton Bonington Campus, Leicestershire, LE12 5RD, UK. ali.mobasheri.manuscripts@gmail.com.
University of Nottingham · GBBruker (United Kingdom) · GBNewcastle University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F017014/1
6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is an inflammatory disease of synovial joints involving the loss and degeneration of articular cartilage. The gold standard for evaluating cartilage loss in OA is the measurement of joint space width on standard radiographs. However, in most cases the diagnosis is made well after the onset of the disease, when the symptoms are well established. Identification of early biomarkers of OA can facilitate earlier diagnosis, improve disease monitoring and predict responses to therapeutic interventions.

methodsThis study describes the bioinformatic analysis of data generated from high throughput proteomics for identification of potential biomarkers of OA. The mass spectrometry data was generated using a canine explant model of articular cartilage treated with the pro-inflammatory cytokine interleukin 1 β (IL-1β). The bioinformatics analysis involved the application of machine learning and network analysis to the proteomic mass spectrometry data. A rule based machine learning technique, BioHEL, was used to create a model that classified the samples into their relevant treatment groups by identifying those proteins that separated samples into their respective groups. The proteins identified were considered to be potential biomarkers. Protein networks were also generated; from these networks, proteins pivotal to the classification were identified.

resultsBioHEL correctly classified eighteen out of twenty-three samples, giving a classification accuracy of 78.3% for the dataset. The dataset included the four classes of control, IL-1β, carprofen, and IL-1β and carprofen together. This exceeded the other machine learners that were used for a comparison, on the same dataset, with the exception of another rule-based method, JRip, which performed equally well. The proteins that were most frequently used in rules generated by BioHEL were found to include a number of relevant proteins including matrix metalloproteinase 3, interleukin 8 and matrix gla protein.

conclusionsUsing this protocol, combining an in vitro model of OA with bioinformatics analysis, a number of relevant extracellular matrix proteins were identified, thereby supporting the application of these bioinformatics tools for analysis of proteomic data from in vitro models of cartilage degradation.

Indexed as

AnimalsArtificial IntelligenceCartilage, ArticularDogsInterleukin-1betaMaleMass SpectrometryOsteoarthritisProteinsProteomeInterleukin-1betaProteinsProteome

Identifiers

PMID24330474
PMCPMC3878677
OpenAlexW2141097399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.